TRI102 in the Treatment of Children With Attention Deficit Hyperactivity Disorder (ADHD)
Status:
Completed
Trial end date:
2014-12-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine whether TRI102 is effective in the treatment of
Attention Deficit Hyperactivity Disorder (ADHD) in children ages 6-12.